Testing effectiveness (Phase 2)Study completedNCT01954745
What this trial is testing
Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma
Who this might be right for
Bile Duct CancerIntrahepatic CholangiocarcinomaCholangiocarcinoma of the Extrahepatic Bile Duct
Massachusetts General Hospital 19